These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 25586405

  • 1. Microscopic nephrocalcinosis in chronic kidney disease patients.
    Evenepoel P, Daenen K, Bammens B, Claes K, Meijers B, Naesens M, Sprangers B, Kuypers D, Lerut E.
    Nephrol Dial Transplant; 2015 May; 30(5):843-8. PubMed ID: 25586405
    [Abstract] [Full Text] [Related]

  • 2. Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Isakova T, Cai X, Lee J, Mehta R, Zhang X, Yang W, Nessel L, Anderson AH, Lo J, Porter A, Nunes JW, Negrea L, Hamm L, Horwitz E, Chen J, Scialla JJ, de Boer IH, Leonard MB, Feldman HI, Wolf M, CRIC Study Investigators.
    Am J Kidney Dis; 2020 Feb; 75(2):235-244. PubMed ID: 31668375
    [Abstract] [Full Text] [Related]

  • 3. The prevalence and detection of chronic kidney disease (CKD)-related metabolic complications as a function of estimated glomerular filtration rate in the oldest old.
    Van Pottelbergh G, Vaes B, Jadoul M, Matheï C, Wallemacq P, Degryse JM.
    Arch Gerontol Geriatr; 2012 Feb; 54(3):e419-25. PubMed ID: 22265240
    [Abstract] [Full Text] [Related]

  • 4. Calcium, phosphate and parathyroid metabolism in kidney transplanted patients.
    Ambrus C, Molnar MZ, Czira ME, Rosivall L, Kiss I, Remport A, Szathmari M, Mucsi I.
    Int Urol Nephrol; 2009 Dec; 41(4):1029-38. PubMed ID: 19701690
    [Abstract] [Full Text] [Related]

  • 5. Vitamin D status and its association with mineral and bone disorder in a multi-ethnic chronic kidney disease population.
    Ngai M, Lin V, Wong HC, Vathsala A, How P.
    Clin Nephrol; 2014 Oct; 82(4):231-9. PubMed ID: 25161115
    [Abstract] [Full Text] [Related]

  • 6. Risk factors and implications associated with ultrasound-diagnosed nephrocalcinosis in cats with chronic kidney disease.
    Tang PK, Geddes RF, Chang YM, Jepson RE, van den Broek DHN, Lötter N, Elliott J.
    J Vet Intern Med; 2024 Oct; 38(3):1563-1576. PubMed ID: 38438128
    [Abstract] [Full Text] [Related]

  • 7. Parathyroid hormone and large related C-terminal fragments increase at different rates with worsening of renal function in chronic kidney disease patients. A possible indicator of bone turnover status?
    Donadio C, Ardini M, Lucchesi A, Donadio E, Cantor T.
    Clin Nephrol; 2007 Mar; 67(3):131-9. PubMed ID: 17390737
    [Abstract] [Full Text] [Related]

  • 8. Management of CKD-MBD in non-dialysis patients under regular nephrology care: a prospective multicenter study.
    Gallieni M, De Luca N, Santoro D, Meneghel G, Formica M, Grandaliano G, Pizzarelli F, Cossu M, Segoloni G, Quintaliani G, Di Giulio S, Pisani A, Malaguti M, Marseglia C, Oldrizzi L, Pacilio M, Conte G, Dal Canton A, Minutolo R.
    J Nephrol; 2016 Feb; 29(1):71-8. PubMed ID: 25986389
    [Abstract] [Full Text] [Related]

  • 9. Association of Drug Effects on Serum Parathyroid Hormone, Phosphorus, and Calcium Levels With Mortality in CKD: A Meta-analysis.
    Palmer SC, Teixeira-Pinto A, Saglimbene V, Craig JC, Macaskill P, Tonelli M, de Berardis G, Ruospo M, Strippoli GF.
    Am J Kidney Dis; 2015 Dec; 66(6):962-71. PubMed ID: 26003472
    [Abstract] [Full Text] [Related]

  • 10. [Management of bone and mineral metabolism disorders before the dialysis stage remains still perfectible. Data from the French Phosphorus and Calcium Survey Photo-Graphe].
    Jean G, Daugas É, Roth H, Drueke T, Bouchet JL, Hannedouche T, London G, Fouque D.
    Nephrol Ther; 2017 Nov; 13(6):470-478. PubMed ID: 28843391
    [Abstract] [Full Text] [Related]

  • 11. Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.
    Craver L, Marco MP, Martínez I, Rue M, Borràs M, Martín ML, Sarró F, Valdivielso JM, Fernández E.
    Nephrol Dial Transplant; 2007 Apr; 22(4):1171-6. PubMed ID: 17205962
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of weekly administration of cholecalciferol on parathyroid hormone in stable kidney-transplanted patients with CKD stage 1-3.
    Sella S, Bonfante L, Fusaro M, Neri F, Plebani M, Zaninotto M, Aghi A, Innico G, Tripepi G, Michielin A, Prandini T, Calò LA, Giannini S.
    Clin Chem Lab Med; 2020 May 05; 59(2):343-351. PubMed ID: 32374278
    [Abstract] [Full Text] [Related]

  • 13. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I, Jaeger P, Ebner L, Wagner CA, Petzold K, Spichtig D, Poster D, Wüthrich RP, Russmann S, Serra AL.
    Nephrol Dial Transplant; 2013 Feb 05; 28(2):352-9. PubMed ID: 23129826
    [Abstract] [Full Text] [Related]

  • 14. The relationship between intact PTH and biointact PTH (1-84) with bone and mineral metabolism in pre-dialysis chronic kidney disease (CKD).
    O'Flaherty D, Sankaralingam A, Scully P, Manghat P, Goldsmith D, Hampson G.
    Clin Biochem; 2013 Oct 05; 46(15):1405-9. PubMed ID: 23830844
    [Abstract] [Full Text] [Related]

  • 15. Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor-23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease.
    Parker VJ, Harjes LM, Dembek K, Young GS, Chew DJ, Toribio RE.
    J Vet Intern Med; 2017 May 05; 31(3):791-798. PubMed ID: 28186657
    [Abstract] [Full Text] [Related]

  • 16. Diabetes modifies effect of high-phosphate diet on fibroblast growth factor-23 in chronic kidney disease.
    Muras K, Masajtis-Zagajewska A, Nowicki M.
    J Clin Endocrinol Metab; 2013 Dec 05; 98(12):E1901-8. PubMed ID: 24092829
    [Abstract] [Full Text] [Related]

  • 17. PTH levels and not serum phosphorus levels are a predictor of the progression of kidney disease in elderly patients with advanced chronic kidney disease.
    Toapanta Gaibor NG, Nava Pérez NC, Martínez Echevers Y, Montes Delgado R, Guerrero Riscos MÁ.
    Nefrologia; 2017 Dec 05; 37(2):149-157. PubMed ID: 27823902
    [Abstract] [Full Text] [Related]

  • 18. Epidemiology and determinants of pruritus in pre-dialysis chronic kidney disease patients.
    Solak B, Acikgoz SB, Sipahi S, Erdem T.
    Int Urol Nephrol; 2016 Apr 05; 48(4):585-91. PubMed ID: 26762886
    [Abstract] [Full Text] [Related]

  • 19. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R, Li S, Chen SC, McCullough PA, Bakris GL.
    Am J Kidney Dis; 2009 Apr 05; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [Abstract] [Full Text] [Related]

  • 20. Multinational observational study on clinical practices and therapeutic management of mineral and bone disorders in patients with chronic kidney disease stages 4, 5, and 5D: The OCEANOS study.
    Shaheen FA, Kurpad R, Al-Sayyari AA, Souqiyyeh MZ, Aljubori H, El Baz T, Kashif W, Tuganbekova S, Kabulbayev K, Jarraya F, Nafar M.
    Saudi J Kidney Dis Transpl; 2016 Mar 05; 27(2):290-304. PubMed ID: 26997382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.